Recognition places Biointron among the top 35% of global performers in sustainability management

Biointron Biological Inc. (Group), a global leader in recombinant antibody discovery and production, has been awarded the EcoVadis Bronze Medal for our commitment to sustainability, corporate responsibility, and ethical business practices.
This recognition places Biointron among the top 35% of companies worldwide evaluated by EcoVadis, a globally trusted provider of business sustainability ratings. The assessment covers four key pillars: environment, labor and human rights, ethics, and sustainable procurement.
Biointron achieved top scores in environmental management, earning a perfect rating for its comprehensive environmental policies and certifications. Our ISO 14001 certification highlights our systematic approach to reducing environmental impact through responsible energy use, waste management, and pollution prevention.
Through continuous improvement initiatives, Biointron integrates sustainability into our daily operations, from optimizing production processes to minimizing emissions and resource consumption, ensuring that innovation and environmental care go hand in hand.
EcoVadis also recognized Biointron for our strong actions in labor and human rights, where we received a perfect score for employee-focused programs and global standards of compliance. Our ISO 45001 certification reflects our proactive approach to occupational health and safety, comprehensive training programs, and commitment to fostering a fair, inclusive, and supportive workplace.
As a trusted partner in antibody research and development, Biointron views sustainability as a cornerstone of long-term success. We continue to strengthen governance systems, promote ethical conduct, and work closely with partners to build a more sustainable biotech ecosystem. Biointron aims to continue to innovate responsibly and contribute to a healthier planet and community.
EcoVadis is a globally recognized provider of sustainability ratings for businesses, assessing more than 150,000 companies across 180 industries. Their methodology evaluates environmental impact, labor and human rights, ethics, and sustainable procurement to provide a comprehensive view of corporate responsibility performance.
Founded in 2012, Biointron is a leading provider of recombinant antibody expression and discovery services, supporting global pharmaceutical and biotech companies with high-quality, efficient solutions for therapeutic antibody development. With a commitment to scientific excellence, customer success, and sustainability, Biointron continues to accelerate innovation in the life sciences industry.
Biointron, a leading contract research organization (CRO) specializing in antibo……
Introducing a new High-throughput Fully Humanized Antibody Discovery Platform wi……
Biointron is proud to share that we have received the 2024 Scientist.com Supplie……
Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.


